SBWire

A lawsuit was filed for investors in Plains Exploration & Production Company (NYSE:PXP) in effort to block the proposed takeover and NYSE:PXP stockholders are encouraged to contact the Shareholders Foundation.

An investigation for Star Scientific, Inc. (NASDAQ:STSI) investors over potential breaches of fiduciary duties by certain directors of Star Scientific, Inc. was announced and current long-term NASDAQ:STSI stockholders should contact the Shareholders Foundation.

An investigation for investors in shares of Micron Technology, Inc. (NASDAQ:MU) over possible breaches of fiduciary duties was announced and current long-term NASDAQ:MU stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com

A lawsuit was filed by an investor in shares of Zagg Inc (NASDAQ:ZAGG) over alleged breaches of fiduciary duty and current long-term NASDAQ:ZAGG stockholders are encouraged to contact the Shareholders Foundation at mail@shareholdersfoundation.com

An investigation on behalf of investors of Compuware Corporation (NASDAQ:CPWR) in connection with a potential takeover was announced and NASDAQ:CPWR stockholders should contact the Shareholders Foundation.

Logbook Loans Centre, a UK-based company that provides its customers with logbook loans, has just announced that it is now offering same day processing. This news comes at a perfect time, as many people across the UK could use some extra funds in order to complete their last-minute holiday shopping.

Legerdemain Magic offers perfect, customized entertainment to make any kind of event amazingly successful. Whether the magician performs on stage or up close and personal, the participants are bound to be intrigued by the performance. Professional Close Up Magician in London Legerdemain Magic founder James Pritchard is an award-winning London magician and member of The Magic Circle.

Recent studies have shown that chocolate provides a number of health benefits when consumed regularly and in moderation. Statistics indicate that weekly ingestion of at least 45 grams of chocolate can reduce the risk of stroke by up to 20 percent. Additionally, dark chocolate that contains at least 70 percent cocoa provides antioxidants and anti inflammatory agents. These chocolates having a high cocoa content have been shown to lead to improved cholesterol levels and lower blood pressure. Chocolate intake of any variety has also been linked to reduced stress and lower blood sugar levels. In answer to these health analyses, Chocolate Express offers the public more than 100 varieties of Leonidas Belgian chocolates.

New Forest Activities is pleased to announce the launch of their one-stop shop programme of activities for hen parties taking place in the Bournemouth area. The 2013 program of activities for Bournemouth hen weekends is designed to provide hens who want to organise a memorable weekend with everything they need under one roof. New Forest Activities can arrange a programme of accommodation, daytime outdoor activities as well as evening entertainment. Recommendations from New Forest Activities staff all come with the benefit of local knowledge of Bournemouth and the New Forest.

GlobalData's clinical trial report, "Aortic Valve Diseases Global Clinical Trials Review, H2, 2012" provides data on the Aortic Valve Diseases clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aortic Valve Diseases. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aortic Valve Diseases. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Nigeria. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the natural gas assets (gas fields, pipelines and LNG terminals) in Nigeria. The report compares the investment environment in Nigeria with other countries in the region. The profiles of the major companies operating in the natural gas sector in Nigeria together with the latest news and deals are also included in the report.

GlobalData's "Power Quarterly Deals Analysis: M&A and Investment Trends - Q3 2012" report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry. The report provides detailed information on M&As, equity/debt offerings, private equity (PE), venture financing and partnership transactions recorded in the power industry in Q3 2012. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, categorized into deal types, segments and geographies. The report also provides information on the top PE, venture capital (VC) and advisory firms in the power industry.

GlobalData's clinical trial report, "Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2012" provides data on the Pulmonary Arterial Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pulmonary Arterial Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pulmonary Arterial Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's mining industry offering, "United States Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape" provides a comprehensive understanding of the Silver mining industry in United States. This report provides historical and forecast data on Silver mine production and primary Silver metal consumption to 2020. In addition to this, the report also includes drivers and restraints affecting the industry, profiles of major Silver mining companies, information on major active and planned mines and regulations governing the industry. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's new report, "North America Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others" provides key market data on the North America Diagnostic Imaging market - Canada and United States. The report provides value (USD million) data for all the market categories - Angio Suites, Bone Densitometers, C-Arms, Computed Tomography Systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems and X-ray Systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

GlobalData's report, North America Maleic Anhydride Industry Outlook to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of North America Maleic Anhydride industry. The research presents major market trends affecting Maleic Anhydride in the region. It provides capacity growth and presents installed capacity by process and technology. In addition, it presents market size, demand and production forecasts, end use demand forecasts, and company shares of major Maleic Anhydride producers in the region. The research also provides price trends and trade balance data. Supply and demand scenario for key countries within the region is also included in the report. Overall, the reports present a comprehensive analysis of the specific petrochemical in the region covering all the major parameters.

GlobalData's clinical trial report, "Osteosarcoma Global Clinical Trials Review, H2, 2012" provides data on the Osteosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Osteosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Osteosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Hyponatremia Global Clinical Trials Review, H2, 2012" provides data on the Hyponatremia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyponatremia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyponatremia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Pharyngeal Neoplasm - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Pharyngeal Neoplasm, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pharyngeal Neoplasm. Pharyngeal Neoplasm - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Lung Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lung Cancer. Lung Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's new report, "Ireland Patient Monitoring Market Outlook to 2018" provides key market data on the Ireland Patient Monitoring market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories - Multiparameter Patient Monitoring, Non-Invasive Blood Pressure Monitors, Patient Monitoring Accessories, Micro-Electromechanical Systems, Neonatal Monitors , Remote Patient Monitoring, and Fetal Monitors. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Global Markets Direct's new report, "Greece Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2018" provides key market data on the Greece Orthopedic Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within twelve market categories - Trauma Fixation, Spinal Surgery, Orthobiologics, Hip Reconstruction, Arthroscopy, Knee Reconstruction, Orthopedic Braces and Supports, Orthopedic Prosthetics, Orthopedic Bone Cement and Casting Materials, Cranio Maxillofacial Fixation (CMF), Other Joint Reconstruction and Orthopedic Tools. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Global Market Direct's pharmaceuticals report, "Palau Pharma, S.A. - Product Pipeline Review - 2012" provides data on the Palau Pharma, S.A.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Postherpetic Neuralgia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Postherpetic Neuralgia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Postherpetic Neuralgia. Postherpetic Neuralgia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

This report is the result of SDI's extensive market and company research covering the global counter IED industry. It provides detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of the leading companies in the industry, and key news.